J2704 HCPCS Level II code: Injection, propofol, 10 mg
J2704 is the HCPCS code for “Injection, propofol, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2704Injection, propofol, 10 mg
Short description: Inj, propofol, 10 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J2704 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2015
Where J2704 sits
- 1J codesDrugs administered other than orally
- 2Active code J2704Injection, propofol, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2704 mean?
J2704 is the HCPCS code for “Injection, propofol, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2704?
CMS lists J2704’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2704
All J codesJ2670Injection, tolazoline hcl, up to 25 mgJ2675Injection, progesterone, per 50 mgJ2679Injection, fluphenazine hcl, 1.25 mgJ2680Injection, fluphenazine decanoate, up to 25 mgJ2690Injection, procainamide hcl, up to 1 gmJ2700Injection, oxacillin sodium, up to 250 mgJ2710Injection, neostigmine methylsulfate, up to 0.5 mgJ2711Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mgJ2720Injection, protamine sulfate, per 10 mgJ2724Injection, protein c concentrate, intravenous, human, 10 iuJ2725Injection, protirelin, per 250 mcgJ2730Injection, pralidoxime chloride, up to 1 gm